Dietary folate and the incidence and prevention of neural tube defects: A proposed triple intervention approach in Israel

Nutrition Reviews

Volumn 60, Issue 10, 2002, Pages 303-307

  Kaluski, D Nitzan ^a   Amitai, Y ^b,c   Haviv, A ^c   Goldsmith, R ^c   Leventhal, A ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c Hebrew University ^*

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Arab; Dietary modification; Folate; Fortification; Israel; Neural tube defects; Supplementation; Women

Indexed keywords

FOLIC ACID;

DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD INTAKE; FOOD PROCESSING; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; INCIDENCE; ISRAEL; MATERNAL NUTRITION; NEURAL TUBE DEFECT; PREGNANCY; PRENATAL CARE; PUBLIC HEALTH; REVIEW;

ADULT; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD HABITS; FOOD, FORTIFIED; HUMANS; INCIDENCE; ISRAEL; NEURAL TUBE DEFECTS;

EID: 0036790799     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/002966402320583424     Document Type: Review

References (42)

1. Zlotogora J, Amitai Y, Nitzan Kaluski D, Leventhal A. Open neural tube defects in Israel 1999-2000. Isr Med J (in press)
2. Elwood JM, Little J, Elwood JH. Epidemiology and control of neural tube defects. New York, NY: Oxford University Press; 1992.
3. Jaber L, Merlob P, Bu X, Rotter JI, Shohat M. Marked parental consanguinity as a cause for increased major malformations in an Israeli Arab community. Am J Med Genet 1992;44:1-6.
4. Zlotogora J. Autosomal recessive diseases among Palestinian Arabs. J Med Genet 1997;34:765-766.
5. Jaber L, Dolfin T, Shohat T, Halpern GJ, Reish O, Fejgin M. Prenatal diagnosis for detecting congenital malformations: acceptance among Israeli Arab women. Isr Med Assoc J 2000;2:346-350.
6. Lewando-Hundt G, Shoham-Vardi I, Beckerleg S, Belmaker I, Kassem F, Jaafar AA. Knowledge, action and resistance: the selective use of pre-natal screening among Bedouin women of the Negev, Israel. Soc Sci Med 2001;52:561-569.
7. Laurence KM. Hydrocephalus and malformations of the central nervous system. In: Keeling JW, ed. Fetal and Neonatal Pathology. Second ed. Heidelberg: Springer-Verlag 1993:541-570.
8. Kaluski DN, Goldsmith R, Arie OM, Mayer C, Green M. The first Israeli national health and nutrition survey (MABAT) as a policy maker. Public Health Rev 2000;28:23-26.
9. Department of Nutrition, Israel Ministry of Health. Folate consumption in Israel. Annual report. Jerusalem: (in press).
10. Bellamy C. The State of the World's Children 2000. New York, NY: 2000.
11. Suitor CW, Bailey LB. Dietary folate equivalents: interpretation and application. J Am Diet Assoc 2000;100:88-94.
12. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 2000;71:121-138.
13. Bailey LB. New standard for dietary folate in pregnant women. Am J Clin Nutr 2000;71:1304s-1307s.
14. Hillman RS. Hematopoietic agents. Growth factor, minerals and vitamins. In: Hillman RS, ed. The Pharmacological Basis of Therapeutics. Ninth ed. New York, NY: McGraw-Hill 1996:1311-1340.
15. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996;347:657-659.
16. Department of Nutrition, Israel Ministry of Health. Israeli sensible nutrition guidelines. Jerusalem: 1997.
17. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morbid Mortal Wkly Rep 1992;41:1-7.
18. 12, Pantothenic Acid, Biotin and Choline. Washington, DC: National Academy Press; 1998.
19. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338:131-137.
20. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835.
21. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-226.
22. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999;341:1485-1490.
23. Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 1998;78:151-161.
24. Centers for Disease Control. Knowledge and use of folic acid by women of childbearing age-United States, 1995 and 1998. MMWR Morbid Mortal Wkly Rep 1999;48:325-357.
25. Ringel S, Lahat E, Elizov T, et al. Awareness of folic acid for neural tube defect prevention among Israeli women. Teratology 1999;60:29-32.
26. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-2986.
27. Smithells RW, Sheppard S. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:647.
28. Romano PS, Waitzman NJ, Scheffler RM, Pi RD. Folic acid fortification of grain: an economic analysis. Am J Public Health 1995;85:667-676.
29. FAO WHO Food Standards CODEX Alimentarius Commission. Micronutrient fortification-technology and quality control. Rome: FAO/WHO; 1994.
30. Federal Register. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Washington, DC: FDA; 1996. Report No. 44.
31. Cuskelly GJ, McNulty H, Scott JM. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: implications for the prevention of neural tube defects. Am J Clin Nutr 1999;70:234-239.
32. Green TJ, Allen OB, O'Connor DL. A three-day weighed food record and a semiquantitative food-frequency questionnaire are valid measures for assessing the folate and vitamin B-12 intakes of women aged 16 to 19 years. J Nutr 1998;128:1665-1671.
33. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA 1995;274:1698-1702.
34. Henderson GI, Perez T, Schenker S, Mackins J, Antony AC. Maternal-to-fetal transfer of 5-methyl-tetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery. J Lab Clin Med 1995;126:184-203.
35. Giugliani ER, Jorge SM, Goncalves AL. Serum and red blood cell folate levels in parturients, in the intervillous space of the placenta and in full-term newborns. J Perinat Med 1985;13:55-59.
36. Huber AM, Wallins LL, DeRusso P. Folate nutriture during pregnancy. J Am Diet Assoc 1988;88:791-795.
37. Lehti KK. Iron, folic acid, and zinc intakes and status of low socioeconomic pregnant and lactating Amazonian women. Eur J Clin Nutr 1989;43:505-513.
38. O'Connor DL. Folate status during pregnancy and lactation 16. In: Allen L, King J, Lonnerdal B, eds. Nutrient regulation during pregnancy, lactation, and infant growth. New York, NY: Plenum Press; 1994.
39. Ek J, Magnus EM. Plasma and red blood cell folate during normal pregnancies. Acta Obstet Gynecol Scand 1981;60:247-251.
40. Hall MH, Pirani BB, Campbell D. The cause of the fall in serum folate in normal pregnancy. Br J Obstet Gynaecol 1976;83:132-136.
41. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis-United States, 1985-1994. MMWR Morbid Mortal Wkly Rep 1995;44:1-13.
42. Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr 1989;50:353-358.